HomeCompareKHOLY vs MRK

KHOLY vs MRK: Dividend Comparison 2026

KHOLY yields 7.26% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KHOLY wins by $55726.65M in total portfolio value
10 years
KHOLY
KHOLY
● Live price
7.26%
Share price
$20.55
Annual div
$1.49
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$55726.70M
Annual income
$54,289,294,443.38
Full KHOLY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — KHOLY vs MRK

📍 KHOLY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKHOLYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KHOLY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KHOLY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KHOLY
Annual income on $10K today (after 15% tax)
$616.72/yr
After 10yr DRIP, annual income (after tax)
$46,145,900,276.87/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, KHOLY beats the other by $46,145,891,948.46/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KHOLY + MRK for your $10,000?

KHOLY: 50%MRK: 50%
100% MRK50/50100% KHOLY
Portfolio after 10yr
$27863.38M
Annual income
$27,144,652,120.76/yr
Blended yield
97.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KHOLY
No analyst data
Altman Z
0.7
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KHOLY buys
0
MRK buys
0
No recent congressional trades found for KHOLY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKHOLYMRK
Forward yield7.26%2.76%
Annual dividend / share$1.49$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$55726.70M$56.8K
Annual income after 10y$54,289,294,443.38$9,798.13
Total dividends collected$55628.12M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KHOLY vs MRK ($10,000, DRIP)

YearKHOLY PortfolioKHOLY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,151$1,451.11$11,206$366.19+$945.00KHOLY
2$16,298$3,295.82$12,650$502.35+$3.6KKHOLY
3$25,701$8,262.58$14,407$694.19+$11.3KKHOLY
4$51,855$24,355.05$16,585$967.82+$35.3KKHOLY
5$147,335$91,849.62$19,342$1,363.89+$128.0KKHOLY
6$645,443$487,794.83$22,913$1,947.19+$622.5KKHOLY
7$4,684,887$3,994,263.14$27,662$2,823.89+$4.66MKHOLY
8$59,203,468$54,190,639.22$34,159$4,173.35+$59.17MKHOLY
9$1,343,372,944$1,280,025,233.25$43,337$6,308.80+$1343.33MKHOLY
10$55,726,703,494$54,289,294,443.38$56,776$9,798.13+$55726.65MKHOLY

KHOLY vs MRK: Complete Analysis 2026

KHOLYStock

Koç Holding A.S., through its subsidiaries, engages in the energy, automotive, consumer durables, finance, and other businesses in Turkey and internationally. The company's energy business operates petroleum refineries; distributes petroleum products and liquefied petroleum gases; and generates electricity through hydroelectric, natural gas, coal, thermal, and solar power and other renewable plants. It serves customers under the Akpa, Aygaz, Lipetgaz, Mogaz, Pursu, Aygaz Dogalaz, Demir Export, Ditas, Opet Fuchs, Opet, THY Opet, Tupras, Elektra Bregenz, and Entek brand names. The company's automotive business provides light commercial vehicles, passenger cars, tractors, buses, and trucks, as well as offers automotive retailing and car rental services. It serves customers under the Ford, Koç Fiat Kredi, Otokar, Avis, Birmot, Budget, Otokoç, Otokoç Otomotiv, Otokoç Sigorta, Alfa Romeo, Ferrari, Fiat, Lancia, Maserati, Otoeksper, Tofas, Case IH, and TürkTraktör. The company's consumer durables business offers white goods, televisions, and air conditioners under the Arçelik, Beko, Leisure, Arctic, Altus, Grundig, Blomberg, Defy, Elektra Bregenz, Flavel, Arçelik LG, TEE, and WAT brand names. Its finance business provides various banking and financial products and services that include private banking, factoring, leasing, portfolio management, and credit cards under the Koçfinans, Yapi Kredi Bankasi, Token, akpakoc, Yapi Kredi Faktoring, Yapi Kredi, Yapi Kredi Leasing, Yapi Kredi Kültür Sanat Yayincilik, Yapi Kredi Portföy Yönetimi, Yapi Kredi Yatirim, and Yapi Kredi Koray brand names. The company's other business offers tomato products and pastes, canned pickles, and ketchups; and pasteurized milk, as well as do it yourself retailing, marina, tourism, and information technology services under various brand names. The company was founded in 1926 and is based in Istanbul, Turkey.

Full KHOLY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this KHOLY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KHOLY vs SCHDKHOLY vs JEPIKHOLY vs OKHOLY vs KOKHOLY vs MAINKHOLY vs JNJKHOLY vs ABBVKHOLY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.